The study, a joint effort by scientists at MassGeneral Hospital for Children and the Johns Hopkins University School of Medicine, involved 40 teenage boys and young men, ages 13 to 27, with moderate to severe autism. 13, the researchers say that many of those who received a daily dose of the …

READ FULL ARTICLE Curated publisher From EurekAlert